Accountable Care OrganizationsAmbulatory Procedure/Imaging CenterAmbulatory/Office-based CareAncillary ServicesAssisted Living FacilitiesBehavioral Health CareCommunity Health CareEmergency DepartmentEmergency Medical ServicesHome CareHospicesHospital InpatientHospital OutpatientHospital â OtherIntensive Care UnitsLong-term Care Facilities - OtherManaged Care PlansNational Public Health ProgramsOtherPatient-centered Medical HomesRegional, County, or City Public Health ProgramsRehabilitation CentersResidential Care FacilitiesRural Health CareSkilled Nursing Facilities/Nursing HomesState/Provincial Public Health ProgramsSubstance Use Treatment Programs/CentersTransitionUnspecified
Cervical cancer screening: percentage of women with invasive cervical cancer—non-squamous cell carcinomas who are diagnosed greater than 5 years since previous Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with invasive cervical cancer—non-squamous cell carcinomas who are diagnosed within greater than 3 to 5 years since previous Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with invasive cervical cancer—non-squamous cell carcinomas who are diagnosed within 0.5 to 3 years since previous Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with invasive cervical cancer—squamous cell carcinoma who are diagnosed greater than 5 years since previous Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with invasive cervical cancer—squamous cell carcinoma who are diagnosed within greater than 3 to 5 years since previous Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with invasive cervical cancer—squamous cell carcinoma who are diagnosed within 0.5 to 3 years since previous Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: age standardized incidence rate per 100,000 women of invasive cervical cancer—squamous cell carcinoma diagnosed in a year.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of Pap tests with ASC-H results that have a histological confirmation of HSIL, carcinoma in situ, or invasive carcinoma within 12 months of the ASC-H Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of Pap tests with an HSIL+ result that have a histological confirmation of HSIL, carcinoma in situ, or invasive carcinoma within 12 months of the HSIL+ Pap test.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with histology of HSIL per 1000 women who had a Pap test in the previous 12 months.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: age standardized incidence rate per 100,000 women of invasive cervical cancer—non-squamous cell carcinoma diagnosed in a year.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of invasive carcinoma of the cervix diagnosed at stage 1 in a 12-month period.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women who had a colposcopy within 12 months of a Pap test with an ASC-H/HSIL+ result who had a histologic investigation within 12 months of the ASC-H/HSIL+ cytological finding.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with a cytological finding of ASC-H/HSIL+ who had a histologic investigation within 12 months of the ASC-H/HSIL+ cytological finding.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: number of days at which 90% of women with a high-grade Pap test result who had a follow-up colposcopy.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of women with a high-grade Pap test result who had a follow-up colposcopy within 6 weeks of the index Pap test report date.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: number of days at which 90% of Pap tests are processed by the lab.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of Pap tests for which the time between the date the Pap test is performed and the date that Pap test is processed by the laboratory is less than or equal to 14 days.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of eligible women who have a subsequent Pap test within 42 months of the index test with a negative result.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
Cervical cancer screening: percentage of eligible women who have a subsequent Pap test within 3 years (36 months) of the index test with a negative result.
- Published By Canadian Partnership Against Cancer, Public Health Agency of Canada
- Measurement Settings Ambulatory/Office-based Care, State/Provincial Public Health Programs
- Professionals Involved In the Delivery of Service
